# Study of Cannabidiol and Neuroimaging on Stress

> **NCT07278505** · PHASE1,PHASE2 · RECRUITING · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 160 (estimated)

## Conditions studied

- Early Life Adversity
- Trauma
- Stress

## Interventions

- **DRUG:** Cannabidiol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07278505
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-28
- **Primary completion:** 2030-02-28
- **Final completion:** 2030-02-28
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2025-12-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07278505

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07278505, "Study of Cannabidiol and Neuroimaging on Stress". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT07278505. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*